Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Tuberculosis and HIV news

Show

From To
TB Alliance Sublicenses Promising Anti-tuberculosis Drug from the Medicines Patent Pool

On World Tuberculosis Day, TB Alliance and the Medicines Patent Pool (MPP) announced a licensing agreement for the clinical development of sutezolid, an antibiotic drug candidate which demonstrated encouraging results in early studies. The sublicense pertains to the development of sutezolid in combination with other TB drugs and follows the MPP's license for the treatment signed with patent holder The Johns Hopkins University in January.

Published
24 March 2017
From
Yahoo Finance
New Tuberculosis Drugs May Become Ineffective: Study

New antibiotics that could treat tuberculosis may rapidly become ineffective, according to new research published by the Lancet ahead of World Tuberculosis Day. The rise in multi-drug resistant tuberculosis, which affected 480,000 people in 2015, could mean that even newly discovered drugs will soon be useless, the study found.

Published
24 March 2017
From
Inter Press Service
WHO issues ethics guidance to protect rights of TB patients

New tuberculosis (TB) ethics guidance, launched today by the World Health Organization (WHO), aims to help ensure that countries implementing the End TB Strategy adhere to sound ethical standards to protect the rights of all those affected.

Published
23 March 2017
From
World Health Organization
Health alert: India has 25% of the world's tuberculosis patients

Rising rates of superbug tuberculosis (TB) are threatening to derail decades of progress against the contagious disease, experts said on Thursday, and new drugs powerful enough to treat them are few and far between.

Published
23 March 2017
From
Hindustan Times
Rise of superbug tuberculosis hampers global control efforts

Rising rates of superbug tuberculosis (TB) are threatening to derail decades of progress against the contagious disease, experts said on Thursday, and new drugs powerful enough to treat them are few and far between.

Published
23 March 2017
From
Reuters
Tuberculosis deaths fall in Europe

The number of people developing and dying from tuberculosis (TB) is falling in Europe, but among the most vulnerable - including migrants, prisoners and people who are HIV positive - there have been worrying increases, data showed on Monday.

Published
21 March 2017
From
Reuters
TB/HIV co-infections up 40 percent across Europe over the last five years

New data released today by the European Centre for Disease Prevention and Control (ECDC) and the WHO Regional Office for Europe ahead of World TB Day show that new tuberculosis (TB) cases and deaths in the 53 countries of the WHO European Region declined each year by 4.3% and 8.5% respectively between 2011 and 2015. However, new TB/HIV co-infections increased by 40% over the same time period.

Published
21 March 2017
From
Eurekalert Inf Dis
‘Significant success’ in reducing TB and HIV/Aids in SA’s prisons

Data presented at a five-day stakeholder meeting shows ‘significant success in screening and treatment for tuberculosis in Free State, Northern Cape and KwaZulu-Natal prisons.

Published
16 March 2017
From
Medical Brief
TB partners, patients ask: How does a bacterium responsible for nearly a third of drug-resistance deaths not make list of R&D priority pathogens?

While the unveiling of a list highlighting the need to fund drug development against specific pathogens represented just a beginning for some antimicrobial resistance fighting efforts, the list represented a setback for TB drug development, advocates say.

Published
02 March 2017
From
Science Speaks
Integrase inhibitors may increase risk of IRIS in late presenters for HIV treatment

HIV integrase inhibitors such as dolutegravir and raltegravir may increase the risk of immune reconstitution inflammatory syndrome (IRIS), studies from the Netherlands and France presented

Published
01 March 2017
By
Keith Alcorn

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.